calmidazolium has been researched along with 4-iodo-2,5-dimethoxyphenylisopropylamine in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chalecka-Franaszek, E; Chen, H; Chuang, DM | 1 |
1 other study(ies) available for calmidazolium and 4-iodo-2,5-dimethoxyphenylisopropylamine
| Article | Year |
|---|---|
5-Hydroxytryptamine2A receptor stimulation induces activator protein-1 and cyclic AMP-responsive element binding with cyclic AMP-responsive element-binding protein and Jun D as common components in cerebellar neurons.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Amphetamines; Animals; Animals, Newborn; Calcium-Calmodulin-Dependent Protein Kinases; Cells, Cultured; Cerebellum; Cyclic AMP Response Element-Binding Protein; Enzyme Inhibitors; Gene Expression Regulation; Imidazoles; Kinetics; Neurons; Proto-Oncogene Proteins c-jun; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2A; Receptors, Serotonin; Serotonin Receptor Agonists; Transcription Factor AP-1; Transcription, Genetic; Up-Regulation | 1999 |